AI
ALKS icon

Atria Investments’s Alkermes ALKS Stock Holding History

Atria Investments’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Buy
+4,100
New +$160K ﹤0.01% 2031

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Atria Investments's ALKS Position: Q2 2026 in Review

Atria Investments opened a new position in Alkermes (ALKS) in Q2 2026: 4,100 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #2031 among its holdings.

424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Atria Investments held 4,100 shares of Alkermes worth $215K as of Q2 2026.
  • Alkermes was a new Atria Investments position in Q2 2026.
  • Alkermes made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #2031 holding.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.